News

Plasma Fractionation – Description of an experience

The history of plasma fractionation began in WWII, with the need to develop blood serum products to help soldiers suffering from shock and burns.

Nowadays, Olsa is helping the fight against important diseases by designing and manufacturing plasma fractionation systems

Check out this relevant and insightful article by Roberto Vassena, Olsa’s director of commercial operations, on the implementation of an impressive plasma fractionation system in a CIS country.

“Plasma Fractionation – Description of an experience”
by Roberto Vassena

 

Make sure to follow our new and improved Linkedin page for Olsa’s latest news and content:

Olsa S.p.A. on Linkedin

 

 

 

Stilmas Americas

1 November 2018

Stilmas Expands its North American Operations with the Acquisition of Mar Cor Purification’s High Purity Water Business Based in Burlington Ontario, Canada

 

Milan, Italy November 1, 2018/PRNewswire/ — Stilmas is pleased to announce that effective November 1, 2018 it has acquired the assets of Mar Cor Purification’s High Purity Water Business based in Burlington, Ontario, Canada. The new company will be named Stilmas Americas, and will serve the North American market, expanding the Mar Cor Purification High Purity water portfolio of products. Mar Cor Purification currently manufactures a line of water purification equipment platforms that are compliant with the current USP and EU Purified Water (PW) and Water for Injection (WFI) standards. They specialize in standard and custom engineered turn-key systems for the Pharmaceutical, Biotech, Cosmetic and Semi-Conductor markets.

The Masco Group, with its Companies Stilmas, Olsa and DOC, is a global market leader in the field of pure water technologies and systems for the pharmaceutical and cosmetic industry.  The Masco Group is headquartered in Milan, Italy, with operations in France, China, Russia and USA. Stilmas manufactures state of the art Pharmaceutical Quality Water Systems that include Multiple Effect Stills, Vapor Compression Stills and Pure Steam Generators along with other standard products.

Alberto Borella – CEO Masco Group: “We have found in the High Purity Business Line of Mar Cor Purification the perfect complement of products and competencies to successfully carry out our vision and grow our business. Stilmas Americas will become the reference clean media provider in North America”.

Benjamin Roczniak – President Stilmas Americas: “We are excited that we now have a complete portfolio of State of the Art Biopharma water products that will allow us to provide our customers with complex turnkey solutions”.

Stilmas Americas will be the hub for selling, engineering, manufacturing and servicing Stilmas equipment in North America, becoming a unique player to offer a complete range of pure media technologies in the North American market.

For further information, visit Stilmas website at www.stilmas.com.

Masco-Group and RAG-Foundation

Settala, 08/06/2017

Masco-Group has retained Industrial Investment Company of
RAG-Foundation as long-term majority shareholder

The Masco Group with its business units Stilmas, Olsa and DOC is a global market leader in the field of pure water technologies and systems for the pharmaceutical and cosmetic industry.

Masco Group has a unique track record and experience of more than 100 years in Pure Water Systems as well as complete solutions for liquid production pharmaceutical plants, including product preparation areas. Moreover, the group offers a wide range of services related to the validation in the pharmaceutical and cosmetic industry. The company has the honor to be a reliable and innovative business partner for the leading global and local pharmaceutical and cosmetic companies.

Taking into account the excellent growth opportunities regarding regional expansion, automation solutions as well as larger turnkey projects including balance of plant systems the ownership family has decided to team up with an experienced business partner enabling Masco not only to keep the traditional values of the company and their independence but also to combine it with the highly interesting knowledge and competencies of a global industrial network.

“We are excited to announce this strategic collaboration with RAG Investment Company which will support the acceleration of our business on the global scale. Our new strategic investor will allow Masco to maintain the entrepreneurial spirit and ensure that our business model, network of customers, partnerships and objectives are even reinforced to achieve new ambitious targets,” said Alberto Borella, CEO Masco Group.

Jürgen Wild the Managing Partner of RAG Investment Company:
“Masco Group is a flagship of northern Italy’s high tech industry which started very early in time to become a global player serving customers around the world. Their innovation spirit was always looking for best-in-class solutions satisfying the highest standards of its superb customer base. In addition, the company also developed forward its offering to customers from products to turnkey solutions. With the unique combination of in-house development, production, validation and service Masco Group is the recognized market leader. We are privileged to become the business partner of choice and will commit ourselves to the future success of this outstanding company.”

The Borella family maintains committed to Masco as shareholder and as board members in the management of the group.

Dr.Eng. Alberto BORELLA

CEO Masco Group

Regulatory update and Technology Innovation

15th February 2017

Masco Group is pleased to invite you to our Seminar, organized in collaboration with Melapack Kft. Process division dedicated to the Pharmaceutical and Cosmetic Industries.

Through the several lectures presented, it will be provided an update about the latest regulatory requirements and an anticipation about the ones that will become effective starting from 2017.

Moreover the latest technological trends related to the manufacturing of pharmaceutical and cosmetic finished products like sterile solutions, suspension and ointments will be shown through specific case studies coming from our experience.

The last part of the Seminar will be dedicated to the Quality matter and it will cover the qualification and validation aspects of material, equipment and containers in contact with the pharmaceutical drug formulation.

Entry is free, however places are limited, please register in advance to confirm your attendance.

For any additional information regarding the participation please fill the form below

 

 

 

Interphex 2016

April 26th - 28th 2016

Booth: 2065

Visit Interphex Website

Powtech 2016

April 19th - 21st 2016

Booth: 4-397

Visit Powtech Website